Stockreport

Dupixent's Impact On Sanofi: A Quantitative Projection Of Its Revenue [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Revenue projections for Dupixent assume stable market share but factor in potential erosion from Lebrikizumab, Depemokimab, and new asthma biologics. Our projections [Read more]